High Expression of Aldolase B Confers a Poor Prognosis for Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy

Background: Colorectal cancer is the third most common cancer in both sex worldwide and it is also the fourth most common cause of cancer mortality. For rectal cancer, neoadjuvant concurrent chemoradiotherapy (CCRT) followed by radical proctectomy is gold standard treatment for patients with stage I...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Cancer
Asıl Yazarlar: Tian, Yu-Feng, Hsieh, Pei-Ling, Lin, Ching-Yih, Sun, Ding-Ping, Sheu, Ming-Jen, Yang, Ching-Chieh, Lin, Li-Ching, He, Hong-Lin, Solórzano, Julia, Li, Chien-Feng, Chang, I-Wei
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Ivyspring International Publisher 2017
Konular:
Research Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5463434/
https://ncbi.nlm.nih.gov/pubmed/28607594
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.18197
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller